Literature DB >> 10325456

Identification of DNA sequences of both genital and cutaneous HPV types in a small number of keratoacanthomas of nonimmunosuppressed patients.

E Stockfleth1, B Meinke, R Arndt, E Christophers, T Meyer.   

Abstract

BACKGROUND: Viral infection was suggested to be etiologically involved in skin tumor development. Data on the association of human papillomavirus (HPV) with keratoacanthomas are still conflicting.
OBJECTIVE: Analysis of HPV infection in keratoacanthomas of the general population.
METHODS: HPV DNA was detected by nested PCR. To include a broad range of both cutaneous and mucosal HPV types, HPV PCR was performed with two sets of degenerate primers.
RESULTS: Considering only beta-globin-positive specimens, HPV DNA was detected in 20% of the specimens obtained from 18% of the patients. The spectrum of HPV types detected contains HPV types 6, 14, 16, 35, 58 and 61. In 1 case, the underlying HPV type was not identified. In 1 specimen with transition towards squamous-cell carcinoma, HPV 16 was detected.
CONCLUSIONS: HPV is probably not generally associated with the etiology of keratoacanthoma but may be relevant in individual cases. Oncogenic HPV types may be cofactors for malignant transformation of initially benign skin lesions like keratoacanthomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325456     DOI: 10.1159/000018086

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Relationship between Human Papilloma Virus and Subungual Keratoacanthoma: Two Case Reports and the Outcomes of Surgical Treatment.

Authors:  Fatih Göktay; Emre Kaynak; Pembegül Güneş; Şirin Yaşar; Zafer Küçükodacı; Sema Aytekin
Journal:  Skin Appendage Disord       Date:  2016-09-10

2.  [Giant keratoacanthoma in an immunocompetent patient with detection of HPV 11].

Authors:  M Niebuhr; R Gutzmer; D Hirschfeld; E Kupsch; B Völker; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2009-03       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.